Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
11p15 4 Microduplication Syndrome C4749508
A rare genetic disorder involving duplication of material on chromosome 11, leading to varied developmental features. Requires individualized medical assessment.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Deletion involving 21q22.11-q22.12 is the defining reported change. | Duplication at 11p15.4 is the defining reported change. | High |
| Development | Developmental delay and intellectual disability may occur. | Developmental features are described as varied; a specific pattern is not established. | Moderate |
| Facial appearance | Distinctive facial features may be present. | Facial findings are not established from the supplied description. | Low |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
Validated testing shows a 21q22.11-q22.12 deletion
The chromosomal region matches the left condition rather than 11p15.4.
High
Planning developmental support after genetic confirmation
Source management emphasizes developmental support and medical monitoring.
Moderate
Severe features without chromosomal confirmation
Severity is reported as severe, but features alone cannot select this diagnosis.
Low
Choose 11p15 4 Microduplication Syndrome C4749508 when
Validated testing shows an 11p15.4 duplication
The chromosomal region matches the right condition.
High
Variable developmental findings need individualized review
The source describes varied features and recommends individualized assessment.
Moderate
Moderate severity is used without genetic results
Reported severity differs, but it is not diagnostic by itself.
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect deletion at 21q22.11-q22.12. | May detect duplication at 11p15.4. | An abnormal result is a finding requiring genetics review, not a diagnosis by itself. |
| Standard karyotype | A small deletion may be missed. | A small duplication may be missed. | A normal karyotype does not exclude either micro-rearrangement. |
| Parental copy-number testing | May clarify inheritance; pattern is not established here. | May clarify inheritance; pattern is not established here. | Useful for counseling, but prognosis still requires clinician interpretation. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- Chronic congenital condition with potentially substantial developmental needs; exact outcome is not established.
- Factors
- Reported severe severity, deletion findings, associated anomalies, and available support.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Chronic condition described as moderate and variable; individual outcome is not established.
- Factors
- Duplication findings, associated clinical features, and individualized care.
Time frame: Lifelong, with congenital onset; precise course is not established.
Genetic confirmation, associated medical issues, developmental support, and clinician follow-up.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental delay | May occur and can be substantial. May occur, but the range is not established. Neither description provides exact developmental milestones. |
| Intellectual disability | Reported as a possible feature. Not specifically established in the supplied source. Formal assessment is needed rather than inference from the syndrome name. |
| Associated medical problems | Monitoring is advised; specific complications are not listed. Individualized assessment is advised; specific complications are not listed. Do not assume organ involvement without clinical evidence. |
Patient education highlights
- HighConfirmation
Symptoms or severity cannot confirm either condition; validated genetic results and specialist review are required.
- HighSupportive care
Care is individualized and may include developmental therapies and medical monitoring.
- MediumFamily counseling
Inheritance and recurrence are not established here and should be discussed with a genetics clinician.